<DOC>
	<DOCNO>NCT01153256</DOCNO>
	<brief_summary>Magnesium inhibitory effect neuromuscular transmission cause decrease muscle fiber membrane excitability . It reduce amount acetylcholine release motor nerve terminal decreasing calcium conductance presynaptic voltage-dependent calcium channel . After pre-treatment magnesium , increase speed onset prolongation recovery period neuromuscular blockade observe non-depolarizing neuromuscular blocking agent ( NMBA ) atracurium , vecuronium rocuronium . Rocuronium currently prefer NMBA use alternative succinylcholine rapid tracheal intubation . As alternative succinylcholine , high dos NMBA test rapid sequence intubation . This excessively high dose rocuronium , however , prolongs duration neuromuscular block may warrant every surgical setting . The reduction onset time rocuronium magnesium pre-treatment make intubation condition rapid much well clinically . It thus interest compare intubation condition standard intubation dose rocuronium magnesium pre-treatment high dose rocuronium standard dose rocuronium .</brief_summary>
	<brief_title>Intubating Condition After Magnesium Pre-treatment</brief_title>
	<detailed_description />
	<mesh_term>Magnesium Sulfate</mesh_term>
	<criteria>patient undergoing operation general anesthesia American Society Anesthesiologist physical status I II 2065 year old male female hepatic renal dysfunction respiratory cardiovascular dysfunction neurologic disorder neuromuscular disease pregnancy body mass index ( BMI ) &gt; 30 kg/m2 &lt; 16.5 kg/m2 anticipate difficult airway high magnesium level normal range preoperative evaluation chronic medication calcium channel blocker magnesium history know allergy magnesium sulphate study drug</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>January 2012</verification_date>
</DOC>